Skip to main content

Media Center

Latest News

This filter choice is only applicable to the "Article" news type.
October 14, 2021

Washington, D.C. – Senator Edward J. Markey (D-Mass.), House Judiciary Committee Chairman Jerrold Nadler (NY-10), Chairman of the Judiciary Subcommittee on Courts, Intellectual Property, and the Internet Hank Johnson (GA-04), and Representative Mondaire Jones (NY-17) released the following statement after the Presidential Commission on the Supreme Court of the United States released its initial draft materials today.


October 7, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) issued the following statement after the U.S. District Court for the Western District of Texas granted the Department of Justice's request for a preliminary injunction blocking enforcement of Texas' law SB 8:


October 1, 2021

Washington, D.C. - Today, House Judiciary Subcommittee on Crime Chair Sheila Jackson Lee (D-TX) and Judiciary Committee Chairman Jerrold Nadler (D-NY), along with Subcommittee Members David N.


September 30, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act:

"H.R. 2884, the 'Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act,' is the final bipartisan measure we are considering today to address ever-increasing medical costs and to help make healthcare more affordable.


September 30, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2021:

"I am proud to have introduced H.R. 3617, the 'Marijuana Opportunity Reinvestment and Expungement Act,' or the 'MORE Act,' joined by my colleagues Representatives Barbara Lee, Earl Blumenauer, Nydia Velazquez, Sheila Jackson Lee, and Hakeem Jeffries, as well as many colleagues on this Committee who have signed on as cosponsors.


September 30, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2116, the Creating a Respectful and Open World for Natural Hair Act of 2021 or the CROWN Act:


September 30, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) issued the following statement after the Committee voted to advance 12 pieces of legislation to the full House of Representatives:


September 29, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2883, the Stop Stalling Access to Affordable Medications Act:

"Today, one quarter of Americans report that it is difficult to afford their medicines. In fact, exorbitant medical bills are one of the major reasons Americans seek bankruptcy relief.


September 29, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Subcommittee on Courts, Intellectual Property, and the Internet Chairman Hank Johnson (D-GA) issued the following joint statement on the Wall Street Journal's report that over 100 federal judges failed to recuse themselves from lawsuits involving companies in which they or their family held a financial interest:


September 29, 2021

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021:

"H.R. 2873, the 'Affordable Prescriptions for Patients Through Promoting Competition Act of 2021' is bipartisan legislation introduced by Antitrust Subcommittee Chairman Cicilline and Ranking Member Ken Buck to end an anti-competitive practice known as product hopping.